TTRX · Categories · Form 4
TTRX - SEC Form 4 insider transactions
Turn Therapeutics Inc. (TTRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for TTRX
- SEC Form 4 filed by Burnam Bradley Evan4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- SEC Form 4 filed by Golden Arthur F4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- SEC Form 4 filed by Burnam Bradley Evan4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- SEC Form 4 filed by Chaudhary Zuraiz4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- Director Dewhurst Martin William was granted 21,882 shares (SEC Form 4)4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- Chief Medical Officer Ghodadra Neilesh Shailesh was granted 10,000 shares (SEC Form 4)4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- Director Kester Kent Edward was granted 10,000 shares (SEC Form 4)4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- SEC Form 4 filed by Officer Chaudhary Zuraiz4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- Director Golden Arthur F was granted 10,000 shares (SEC Form 4)4 - Turn Therapeutics Inc. (0002023016) (Issuer)
- Director Gengos Andrew was granted 10,000 shares (SEC Form 4)4 - Turn Therapeutics Inc. (0002023016) (Issuer)